Among GLP-1 users, its emotional connection score climbs from 3.4 to 4.2 on a 7-point scale, the largest EC gain of any brand in the 59% MMS tier
In high-income nations with established diabetes care systems, GLP-1 receptor agonists exhibit advantageous cost-effectiveness ratios when accounting for cardiovascular and renal protective benefits, with incremental cost-effectiveness ratios generally falling below $50,000 per quality-adjusted life year (QALY) for high-risk patients (Kong et al
Three dual agonists (peptide 15, MEDI0382 and SAR425899) and one triple agonist (peptide 20) were evaluated at GLP-1R and GCGR, relative to the native peptidic ligands (GLP-1 and glucagon)
Older adults should be especially aggressive about dental monitoring and preventive oral care when starting any GLP-1 medication
With our user-friendly tool, you can track your symptoms, find helpful tips and resources to aid in your treatment adjustment, and connect with others on a similar path